866-997-4948(US-Canada Toll Free)

Prostate Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Published By :

Transparency

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : 171 Pages

Global Prostate Cancer Therapeutics Market: Overview

This report on the prostate cancer therapeutics market analyzes the current and future scenario of the global market. Increasing prevalence of prostate cancer, launch of promising emerging therapies, as well as innovation in the development of new drugs & therapeutic biological products, and high growth in hormone-refractory prostate cancer drug due to lesser side effects are some of the drivers expected to drive the global prostate cancer therapeutics market during the forecast period.

The global prostate cancer therapeutics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country’s market with respect to the segments based on therapy type, distribution channels and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global prostate cancer therapeutics market.

Global Prostate Cancer Therapeutics Market: Key Segments

Based on therapy type, the market has been segmented into hormone therapy, chemotherapy, biologic therapy and targeted therapy. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference from oncologists for treating the prostate cancer with various drug classes. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on distribution channels, the global prostate cancer therapeutics market has been segmented into hospital pharmacy, retail pharmacy, online sales and others. The market segments have been extensively analyzed based on increase in demand for disease treatment among prostate cancer patients. Increased patient hospitalization for the treatment of prostate cancer are driving the market share of hospital pharmacy segment. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Prostate Cancer Therapeutics Market: Regional Outlook

Geographically, the global prostate cancer therapeutics market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Companies Mentioned in Report

The report also profiles major players in the global prostate cancer therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include players in the global prostate cancer therapeutics market are Amgen, Inc., Johnson & Johnson (Janssen Biotech, Inc.), Pfizer, Inc., AstraZeneca, AbbVie, Inc., Bayer AG, Ipsen Group, Sanofi, Endo Pharmaceuticals, Inc., Dendreon Corporation (Sanpower Group Co. Ltd.) and others.

The Global Prostate Cancer Therapeutics Market is segmented as given below:

Global Prostate Cancer Therapeutics Market, by Therapy

  • Hormone Therapy
  • Luteinizing Hormone-Releasing Hormone Analogs
  • Luteinizing Hormone-Releasing Hormone Antagonists
  • Antiandrogens
  • Chemotherapy
  • Systemic Chemotherapy
  • Regional Chemotherapy
  • Biologic Therapy
  • Targeted Therapy

Global Prostate Cancer Therapeutics Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Others

Global Prostate Cancer Therapeutics Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • India
  • China
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa

Table of Content

Chapter 1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology 
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary 
3.1. Global Prostate Cancer Therapeutics Market : Snapshot, 2015
3.2. Global Prostate Cancer Therapeutics Market : Opportunity Map

Chapter 4. Market Overview
4.1. Product Overview
4.2. Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2014–2024 
4.3. Global Prostate Cancer Therapeutics Market Outlook
4.4. Global Prostate Cancer Therapeutics Market : Key Industry Events
4.5. Global Prostate Cancer Therapeutics Market : Porter's Analysis
4.6. Global Prostate Cancer Therapeutics Market : Pipeline Analysis
4.7. Key Product Opportunities

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increasing prevalence of prostate cancer 
5.2.2. Launch of promising emerging therapies
5.2.3. Innovation in the development of new drugs and therapeutic biological products
5.2.4. High growth in hormone-refractory prostate cancer drug due to lesser side effects
5.3. Restrains
5.3.1. High cost of treatment
5.3.2. Reluctance toward adoption of premium treatments
5.4. Opportunity Analysis
5.5. Opportunities
5.5.1. Large undiagnosed patient population
5.5.2. Rise in funding from both public and private sector in the field of drug development
5.6. Key Trends 
5.6.1. Increasing application of biotechnology in anticancer drugs development
5.6.2. New drugs entering the market with higher costs 
5.6.3. Oral drugs account for a large share of the oncology drugs market

Chapter 6. Prostate Cancer Therapeutics Market Analysis, by Product Type
6.1. Prostate Cancer Therapeutics Market Analysis, by Therapy
6.2. Key Findings
6.3. Introduction
6.4. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Therapy
6.5. Prostate Cancer Therapeutics Market Analysis, by Therapy 
6.5.1. Hormone Therapy
6.5.2. Luteinizing Hormone-Releasing Hormone Analogs
6.5.3. Luteinizing Hormone-Releasing Hormone Antagonists
6.5.4. Antiandrogens
6.6. Chemotherapy
6.6.1. Systemic Chemotherapy
6.6.2. Regional Chemotherapy
6.7. Biologic Therapy
6.8. Targeted Therapy
6.9. Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024
6.10. Key Trends

Chapter 7. Prostate Cancer Therapeutics Market Analysis, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.3. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Distribution Channel
7.4. Prostate Cancer Therapeutics Market Analysis, by Distribution Channel
7.4.1. Hospital Pharmacy 
7.4.2. Retail Pharmacy 
7.4.3. Online Sales 
7.4.4. Others
7.5. Market Attractiveness Analysis, by Distribution Channel 
7.6. Key Trends

Chapter 8. Prostate Cancer Therapeutics Market Analysis, by Region
8.1. Global Prostate Cancer Therapeutics Market Snapshot, by Country
8.2. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Region
8.3. Prostate Cancer Therapeutics Market Forecast, by Region
8.4. Prostate Cancer Therapeutics Market Attractiveness Analysis, by Region, 2016-2024 

Chapter 9. North America Prostate Cancer Therapeutics Market Analysis
9.1. Key Findings
9.2. North America Prostate Cancer Therapeutics Market Overview
9.3. North America Market Value Share Analysis, by Therapy
9.4. North America Market Forecast, by Therapy
9.4.1. Hormone Therapy
9.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
9.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
9.4.1.3. Antiandrogens
9.4.2. Chemotherapy
9.4.2.1. Systemic Chemotherapy
9.4.2.2. Regional Chemotherapy
9.4.3. Biologic Therapy
9.4.4. Targeted Therapy
9.5. North America Market Value Share Analysis, by Distribution Channel
9.6. North America Market Forecast, by Distribution Channel
9.6.1. Hospital Pharmacy
9.6.2. Retail Pharmacy
9.6.3. Online Sales
9.6.4. Others
9.7. Market Analysis, by Country
9.8. Market Value Share Analysis, by Country
9.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
9.9.1. U.S.
9.9.2. Canada
9.10. Market Attractiveness Analysis
9.10.1. By Product 
9.10.2. By Distribution Channel
9.10.3. By Country
9.11. Market Trends

Chapter 10. Europe Prostate Cancer Therapeutics Market Analysis
10.1. Key Findings
10.2. Europe Prostate Cancer Therapeutics Market Overview
10.3. Europe Market Value Share Analysis, by Therapy
10.4. Europe Market Forecast, by Therapy
10.4.1. Hormone Therapy
10.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
10.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
10.4.1.3. Antiandrogens
10.4.2. Chemotherapy
10.4.2.1. Systemic Chemotherapy
10.4.2.2. Regional Chemotherapy
10.4.3. Biologic Therapy
10.4.4. Targeted Therapy
10.5. Europe Market Value Share Analysis, by Distribution Channel
10.6. Europe Market Forecast, by Distribution Channel
10.6.1. Hospital Pharmacy
10.6.2. Retail Pharmacy
10.6.3. Online Sales
10.6.4. Others
10.7. Market Analysis, by Country
10.8. Market Value Share Analysis, by Country
10.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
10.9.1. U.K.
10.9.2. Germany
10.9.3. Italy
10.9.4. France
10.9.5. Spain
10.9.6. Russia
10.9.7. Rest of Europe
10.10. Market Attractiveness Analysis
10.10.1. By Product 
10.10.2. By Distribution Channel
10.10.3. By Country
10.11. Market Trends

Chapter 11. Asia Pacific Prostate Cancer Therapeutics Market Analysis
11.1. Key Findings
11.2. Asia Pacific Prostate Cancer Therapeutics Market Overview
11.3. Asia Pacific Market Value Share Analysis, by Therapy
11.4. Asia Pacific Market Forecast, by Therapy
11.4.1. Hormone Therapy
11.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
11.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
11.4.1.3. Antiandrogens
11.4.2. Chemotherapy
11.4.2.1. Systemic Chemotherapy
11.4.2.2. Regional Chemotherapy
11.4.3. Biologic Therapy
11.4.4. Targeted Therapy
11.5. Asia Pacific Market Value Share Analysis, by Distribution Channel
11.6. Asia Pacific Market Forecast, by Distribution Channel
11.6.1. Hospital Pharmacy
11.6.2. Retail Pharmacy
11.6.3. Online Sales
11.6.4. Others
11.7. Market Analysis, by Country
11.8. Market Value Share Analysis, by Country
11.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
11.9.1. China
11.9.2. Japan
11.9.3. India
11.9.4. Australia & New Zealand
11.9.5. Rest of Asia Pacific
11.10. Market Attractiveness Analysis
11.10.1. By Product 
11.10.2. By Distribution Channel
11.10.3. By Country
11.11. Market Trends

Chapter 12. Latin America Prostate Cancer Therapeutics Market Analysis
12.1. Key Findings
12.2. Latin America Prostate Cancer Therapeutics Market Overview
12.3. Latin America Market Value Share Analysis, by Therapy
12.4. Latin America Market Forecast, by Therapy
12.4.1. Hormone Therapy
12.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
12.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
12.4.1.3. Antiandrogens
12.4.2. Chemotherapy
12.4.2.1. Systemic Chemotherapy
12.4.2.2. Regional Chemotherapy
12.4.3. Biologic Therapy
12.4.4. Targeted Therapy
12.5. Latin America Market Value Share Analysis, by Distribution Channel
12.6. Latin America Market Forecast, by Distribution Channel
12.6.1. Hospital Pharmacy
12.6.2. Retail Pharmacy
12.6.3. Online Sales
12.6.4. Others
12.7. Market Analysis, by Country
12.8. Market Value Share Analysis, by Country
12.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
12.9.1. Brazil
12.9.2. Mexico
12.9.3. Rest of Latin America
12.10. Market Attractiveness Analysis
12.10.1. By Product 
12.10.2. By Distribution Channel
12.10.3. By Country
12.11. Market Trends

Chapter 13. Middle East & Africa Prostate Cancer Therapeutics Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Prostate Cancer Therapeutics Market Overview
13.3. Middle East & Africa Market Value Share Analysis, by Therapy
13.4. Middle East & Africa Market Forecast, by Therapy
13.4.1. Hormone Therapy
13.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
13.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
13.4.1.3. Antiandrogens
13.4.2. Chemotherapy
13.4.2.1. Systemic Chemotherapy
13.4.2.2. Regional Chemotherapy
13.4.3. Biologic Therapy
13.4.4. Targeted Therapy
13.5. Middle East & Africa Market Value Share Analysis, by Distribution Channel
13.6. Middle East & Africa Market Forecast, by Distribution Channel
13.6.1. Hospital Pharmacy
13.6.2. Retail Pharmacy
13.6.3. Online Sales 
13.6.4. Others
13.7. Market Analysis, by Country
13.8. Market Value Share Analysis, by Country
13.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
13.9.1. Brazil
13.9.2. Mexico
13.9.3. Rest of Latin America
13.10. Market Attractiveness Analysis
13.10.1. By Product 
13.10.2. By Distribution Channel
13.10.3. By Country
13.11. Market Trends

Chapter 14. Company Profiles
14.1. Prostate Cancer Therapeutics Market Share Analysis, by Company, 2016 (Estimated)
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Amgen, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Johnson & Johnson (Janssen Biotech, Inc.)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Pfizer, Inc. 
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. AstraZeneca
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. AbbVie, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Bayer AG 
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Ipsen Group
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Sanofi
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Endo Pharmaceuticals, Inc. 
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Dendreon Corporation (Sanpower Group Co. Ltd.) 
14.3.10.1. Company Overview (HQ, Business Segments,)
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview

List of Table

Table 1: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 2: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 3: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 4: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 5: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 6: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 7: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 8: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 9: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 10: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 11: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 12: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 13: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 14: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 15: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 16: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 17: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 18: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 19: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 20: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 21: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 22: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 23: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 24: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 25: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 26: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 27: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 28: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy (Therapy), 2014–2024
Table 29: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 30: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024

List of Chart

Figure 1: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 3: Global Hormone Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 4: Global Chemotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 5: Global Biologic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 6: Global Targeted Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 7: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016–2024
Figure 8: Global Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 9: Global Hospital Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 10: Global Retail Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 11: Global Online Sales Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 12: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 13: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 14: Global Prostate Cancer Therapeutics Market Value Share, by Region, 2016 and 2024
Figure 15: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Region, 2016–2024
Figure 16: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 17: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016–2024
Figure 18: North America Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 19: North America Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 20: North America Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 21: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016–2024
Figure 22: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 23: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 24: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016–2024
Figure 25: Europe Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 26: Europe Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 27: Europe Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 28: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016–2024
Figure 29: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 30: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 31: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016-2024
Figure 32: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 33: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 34: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 35: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024
Figure 36: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016-2024
Figure 37: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 38: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016-2024
Figure 39: Latin America Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 40: Latin America Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 41: Latin America Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 42: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024
Figure 43: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016-2024
Figure 44: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 45: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016-2024
Figure 46: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 47: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 48: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 49: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024
Figure 50: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016-2024
Figure 51: Global Prostate Cancer Therapeutics Market Share Analysis, by Company, 2016 (Estimated)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *